Literature DB >> 19005478

Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.

H Merle-Béral, S Barbier, G Roué, M Bras, M Sarfati, S A Susin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19005478     DOI： 10.1038/leu.2008.321

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.

Authors:  Sandrine Barbier; Laurent Chatre; Marlène Bras; Patricia Sancho; Gaël Roué; Clémence Virely; Victor J Yuste; Sylvie Baudet; Manuel Rubio; Josep E Esquerda; Marika Sarfati; Hélène Merle-Béral; Santos A Susin
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

2.  Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.

Authors:  Elodie Pramil; Linda Herbi Bastian; Thomas Denèfle; Fariba Nemati; Malina Xiao; Eva Lardé; Karim Maloum; Damien Roos-Weil; Elise Chapiro; Magali Le Garff-Tavernier; Frédéric Davi; Didier Decaudin; Marika Sarfati; Florence Nguyen-Khac; Hélène Merle-Béral; Philippe Karoyan; Santos A Susin
Journal:  Blood Adv       Date:  2019-10-22

3.  Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

Authors:  Waleed Alduaij; Andrei Ivanov; Jamie Honeychurch; Eleanor J Cheadle; Sandeep Potluri; Sean H Lim; Kazuyuki Shimada; Claude H T Chan; Alison Tutt; Stephen A Beers; Martin J Glennie; Mark S Cragg; Tim M Illidge
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

4.  CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.

Authors:  Ana-Carolina Martinez-Torres; Claire Quiney; Tarik Attout; Heloïse Boullet; Linda Herbi; Laura Vela; Sandrine Barbier; Danielle Chateau; Elise Chapiro; Florence Nguyen-Khac; Frédéric Davi; Magali Le Garff-Tavernier; Roba Moumné; Marika Sarfati; Philippe Karoyan; Hélène Merle-Béral; Pierre Launay; Santos A Susin
Journal:  PLoS Med       Date:  2015-03-03       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.